Disease/Infection News

RSS

Researchers receive $2.95 million grant to create improved diagnostics for worm infections

Global campaigns to eliminate two tropical parasitic worm infections have been hindered by a lack of good diagnostic tools.

7 Jan 2021

Despite reopening of schools, serious COVID-19 is rare among children

Sweden was one of only a few countries that kept preschools, primary and lower secondary schools open during the spring of the pandemic year of 2020.

7 Jan 2021

Scientific experts help fight the spread of misinformation about COVID-19 vaccines

A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

7 Jan 2021

New peptide can target specific pathogen without damaging the good bacteria

Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust.

7 Jan 2021

Patients with heart failure should take more precautions against COVID-19

Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).

7 Jan 2021

Scientists to help nursing homes implement best practices to mitigate COVID-19 impact

Researchers in Georgia State University's School of Public Health and Emory University's School of Medicine have received a $600,000 grant from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality to help nursing homes implement practices to mitigate the impact of COVID-19 and stop the spread of the SARS-CoV-2 virus.

7 Jan 2021

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

The onset of the coronavirus disease 2019 (COVID-19) pandemic led to severe restrictions on public mobility and interaction, national or state-wide lockdowns, school and workplace closures, and curfews. The result was widespread economic hardship, in addition to the toll on health.

7 Jan 2021

Study: Durable immunity against secondary COVID-19 disease is possible in most individuals

Researchers who studied antibody and immune cell responses in more than 180 men and women who had recovered from COVID-19 report these patients' immune memory to the virus - across all immune cell types studied - was measurable for up to 8 months after symptoms appeared.

7 Jan 2021

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is thought to have a zoonotic origin, perhaps originating in a bat coronavirus with an unknown intermediate host. It is not only very infectious but has been found to infect a wide range of mammals, including dogs, cats, ferrets, hamsters, and minks, besides non-human primates. This range may be still higher, claims a recent preprint that appeared in January 2021 on the bioRxiv server.

6 Jan 2021

Researchers analyze evaporation and propagation of respiratory droplets of COVID-19 patients

COVID-19 can be transmitted when an infected person talks, coughs, sneezes or sings, expelling virus-containing respiratory droplets that can reach the mouth, nose or eyes of previously uninfected people.

6 Jan 2021

Adaptive immune system against COVID-19 can last for at least eight months

New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight re-infection.

6 Jan 2021

Is one-dose COVID-19 vaccination better than two?

A recent study published on the preprint server medRxiv in December 2020 reflects on the possibility of using a single-dose vaccine regimen to accomplish large-scale vaccination as early as possible.

6 Jan 2021

Non-toxic versions of botulism toxins can deliver therapeutic antibodies to treat botulism

Taking advantage of the chemical properties of botulism toxins, two teams of researchers have fashioned non-toxic versions of these compounds that can deliver therapeutic antibodies to treat botulism, a potentially fatal disease with few approved treatments.

6 Jan 2021

Low acceptance of COVID-19 vaccine among healthcare workers in USA

A recent preprint research paper published on the medRxiv server in January 2021 reports that vaccine acceptance is low even among healthcare workers (HCWs) in the USA.

6 Jan 2021

Increased socializing may have jeopardized lockdown benefit in England

Researchers in the UK report that much of the potential beneficial impact of the November 2020 English National lockdown on the coronavirus disease 2019 (COVID-19) epidemic was likely undermined in many areas due to increased socializing in the days running up to its implementation.

6 Jan 2021

More stringent measures may be needed to control new SARS-CoV-2 B.1.1.7 variant in England

Researchers in the UK have conducted a comprehensive epidemiologic analysis of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in an effort to learn more about the expanded range and frequency of coronavirus disease 2019 (COVID-19) cases in England.

6 Jan 2021

In-silico modeling provides new understanding of immune response to SARS-CoV-2

The COVID-19 pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has crippled global healthcare systems and triggered an economic crisis in many countries. The pandemic is not showing signs of a slowdown even in 2021 with a new and more infectious variant of the virus wreaking havoc in the UK and many other parts of the world.

6 Jan 2021

Researchers use network-based approach to examine the impact of policies and vaccination strategies

Predicting the spread of COVID-19 using standard statistical models has its challenges, which is why two Iowa State University researchers developed a network-based approach to look at the impact of specific policies and vaccination strategies throughout the many stages of the pandemic.

6 Jan 2021

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.

6 Jan 2021

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

In a recent bioRxiv* preprint paper, US researchers mapped in detail how mutations to the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected antibody binding in convalescent human serum – and revealed that it is influenced by mutations at only a handful of dominant epitopes.

6 Jan 2021

Disease/Infection News

Researchers receive $2.95 million grant to create improved diagnostics for worm infections

Despite reopening of schools, serious COVID-19 is rare among children

Scientific experts help fight the spread of misinformation about COVID-19 vaccines

New peptide can target specific pathogen without damaging the good bacteria

Patients with heart failure should take more precautions against COVID-19

Scientists to help nursing homes implement best practices to mitigate COVID-19 impact

Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate

Study: Durable immunity against secondary COVID-19 disease is possible in most individuals

ACE2 receptor is responsible for the wide host range of SARS-CoV-2

Researchers analyze evaporation and propagation of respiratory droplets of COVID-19 patients

Adaptive immune system against COVID-19 can last for at least eight months

Is one-dose COVID-19 vaccination better than two?

Non-toxic versions of botulism toxins can deliver therapeutic antibodies to treat botulism

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Increased socializing may have jeopardized lockdown benefit in England

More stringent measures may be needed to control new SARS-CoV-2 B.1.1.7 variant in England

In-silico modeling provides new understanding of immune response to SARS-CoV-2

Researchers use network-based approach to examine the impact of policies and vaccination strategies

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News